Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2020
Is Levodopa Response a Valid Indicator of Parkinson's Disease?W R Wayne Martin, Michael Miles, Qiaonan Zhong, et al.
Brain : a Journal of Neurology|January 12, 2026
Study of blood linear RNA nominates CD55 and DLD as early-stage biomarkers for Parkinson's siseaseAleksandra Beric, Sarp Sahin, Santiago Sanchez, et al.
Annals of Clinical and Translational Neurology|November 5, 2020
Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's diseaseCharles D Chen, Timothy R Holden, Brian A Gordon, et al.
Alzheimer'S Research & Therapy|September 27, 2018
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's diseaseUmesh Gangishetti, J Christina Howell, Richard J Perrin, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
A Comprehensive Study of Circulating Blood Linear RNA nominates CD55 and DLD as novel causal genes and early-stage biomarkers for Parkinson's DiseaseAleksandra Beric, Sarp Sahin, Santiago Sanchez, et al.
Parkinsonism & Related Disorders|December 10, 2025
Longitudinal brain morphometry in Parkinson's disease clinical subtypes: Distinct signatures forecast behavioral change within subtypesAbdulmunaim M Eid, Sarah Grossen, Aaron Tanenbaum, et al.
Neurobiology of Aging|October 16, 2021
Regional age-related atrophy after screening for preclinical alzheimer diseaseLauren N Koenig, Pamela LaMontagne, Matthew F Glasser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumNelly Joseph-Mathurin, Katherine Gong, Gengsheng Chen, et al.
Annals of Clinical and Translational Neurology|January 21, 2022
Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementiaRebecca L Miller, Dhruva D Dhavale, Jennifer Y O'Shea, et al.
Pageof 16